Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Kilitch Drugs India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended September 30, 2016
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Kilitch Drugs India Ltd has informed BSE regarding the details of Voting results at the 24th Annual General Meeting (AGM) of the Company held on September 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report and Proceedings of the Meeting in this regard. Kilitch Drugs arm buys land for set up plant in Ethiopia
Kilitch Drugs (India) on Monday informed the exchanges that its unit Kilitch Estro Biotech Plc has acquired land for setting up a pharma plant in Ethiopia. The Bureau of Rural Land and Environmental Allotment of Land in Federal Democratic Republic of Ethiopia to Kilitch Estro Biotech Plc
Kilitch Drugs India Ltd has informed BSE regarding "Allotment of Land in Federal Democratic Republic of Ethiopia to Kilitch Estro Biotech Plc". Standalone Financial Results, Limited Review Report for June 30, 2016
Kilitch Drugs India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Fixes Book Closure for AGM
Kilitch Drugs India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2016 to September 30, 2016 (both days inclusive) for the purpose of 24th Annual General Meeting (AGM) of the Company to be held on September 30, 2016. Outcome of Board Meeting
Kilitch Drugs India Ltd has informed BSE the Board of Directors of the Company held on August 12, 2016, inter alia, has:1. Appointed Mr. Deep Shukla, Practicing Company Secretary as a Scrutinizer to conduct the entire voting Process and voting done through physical ballot paper at the 24th ACM of the Company [including e-voting] and to submit the Report for declaration of the results thereof.... Shareholding for the Period Ended March 31, 2016
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Shareholding for the Period Ended June 30, 2016
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here